Literature DB >> 10232882

Simultaneous involvement of the jejunum and the colon by type-1 neurofibromatosis.

T Artaza1, J F García, C González, M Amengual, A Mazarro, R Rodríguez, J J Sánchez.   

Abstract

Type-1 neurofibromatosis (NF-1) or Von Recklinghausen disease is an autosomal dominant hereditary condition that may affect the gastrointestinal tract in 25% of cases and which takes three main forms: ganglioneuromatosis, stromal tumors, and tumors in the duodenum and periampullar region. Not infrequently, these patients present with gastrointestinal bleeding. We present the case of a 48-year-old patient diagnosed as having NF-1, with relapsing episodes of gastrointestinal hemorrhage, in which we discovered the simultaneous presence of a stromal tumor in the jejunum together with polypoid and diffuse ganglioneuromatosis in the colon.

Entities:  

Mesh:

Year:  1999        PMID: 10232882     DOI: 10.1080/00365529950173780

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Intra-abdominal plexiform neurofibromatosis including periportal, mesentery, and gastrointestinal tract involvement in neurofibromatosis type 1: case report and review of the literature.

Authors:  Takashi Fujisawa; Masafumi Takata; Sachiko Ouchi; Shigemitsu Ueyama; Takahiro Nakajima; Masaaki Mitsutsuji; Takashi Kawamura; Masanori Toyoda; Akiji Okamura
Journal:  Clin J Gastroenterol       Date:  2011-07-24

2.  Concomitant compostite adrenal phoechromocytoma, multipte gastric stromal tumours and pseudohermaphrodism in a patient with von Recklinghausen's disease.

Authors:  Dean Lisewski; Simon Ryan; Ee Mun Lim; Felicity Frost; Hieu Nguyen
Journal:  Int Semin Surg Oncol       Date:  2006-04-26

3.  Diffuse Intestinal Ganglioneuromatosis Showing Multiple Large Bowel Ulcers in a Patient with Neurofibromatosis Type 1.

Authors:  Masaya Iwamuro; Rika Omote; Takehiro Tanaka; Naruhiko Sunada; Takahiro Nada; Yoshitaka Kondo; Soichiro Nose; Mitsuhiko Kawaguchi; Fumio Otsuka; Hiroyuki Okada
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.